Flurbiprofen and intraocular pressure

D. K. Gieser, E. Hodapp, I. Goldberg, M. A. Kass, B. Becker

Research output: Contribution to journalArticlepeer-review

22 Scopus citations


Systemic or topical administration of corticosteroids may produce a rise in intraocular pressure (IOP). Nonsteroidal anti-inflammatory drugs (NSAI drugs) are alternative therapy for ocular inflammatory disease. Flurbiprofen, a new NSAI drug, was tested in double-masked fashion to delineate its effect on IOP. Flurbiprofen did not alter IOP in known high corticosteroid responders nor did it block corticosteroid-induced ocular hypertension.

Original languageEnglish
Pages (from-to)831-833
Number of pages3
JournalAnnals of ophthalmology
Issue number7
StatePublished - Dec 1 1981


Dive into the research topics of 'Flurbiprofen and intraocular pressure'. Together they form a unique fingerprint.

Cite this